ZEFYLTI 30 MU/0.5 ml, solution for injection/for infusion in a pre-filled syringe 5 syringes of 0.5 ml
Active ingredients: Filgrastim
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection or infusion5 syringes of 0.5 mlintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZEFYLTI 30 MU/0,5 mL, solution injectable/pour perfusion en seringue préremplie
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 5 seringue(s) préremplie(s) en verre de 0,5 ml avec protège-aiguille
- Marketing authorisation holder
- CURATEQ BIOLOGICS (MALTE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Jul 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
66491564CIP73032111CIP133400930321119Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FILGRASTIMsolution | 300 microgrammes (30 MU) · une seringue préremplie de 0,5 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.